ArticleJournal for immunotherapy of cancer2023

CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models.

Jian Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.